Priority Date: 06.06.16 (US 201662346344P)

TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE

  • Application ID: EP17810774
  • Status: █ Request for examination was made

Applicant

Technology company logo small
Celgene Corporation
Technology Company

Attorney

Employment test 1001 - 5000 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna jones day
operating since 1893
1302.36
Jones Day
Headquarter in Cleveland and 38 offices
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Jones Day is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.06.2016 - Priority Date (US 201662346344P)
  • 14.12.2017 - Publication A1 (WO2017214014)
  • 10.04.2019 - Publication A1 (EP3463358)

IPC Classification